We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Quan Capital

News List

Alebund Pharmaceuticals Raises $60 million in Series B Financing Round to Accelerate Its Development of Innovative Drugs and Total Solutions for the Treatment of Renal Diseases prnasia
May 10, 2021
Alebund Pharmaceuticals today announced that it has raised $60 million in its Series B financing round which was led by Quan Capital, and followed by a prominent sovereign wealth fund, 3E Bioventures Capital, and Sherpa Healthcare Partners.
Innoforce Pharmaceuticals Completes 625M CNY ($96M) Series A Financing prnasia
March 22, 2021
Innoforce Pharmaceuticals, a biopharmaceutical innovation and partnership company, announced today the completion of a 625M CNY ($96M) Series A financing, which follows a 170M CNY ($24M) Pre-A financing completed in June 2020.